141 related articles for article (PubMed ID: 20551529)
1. Immunohistochemical study of epithelial-myofibroblast interaction in Barrett metaplasia.
Ochicha O; Pringle JH; Mohammed AZ
Indian J Pathol Microbiol; 2010; 53(2):262-6. PubMed ID: 20551529
[TBL] [Abstract][Full Text] [Related]
2. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
3. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.
Kazumori H; Ishihara S; Kinoshita Y
Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512
[TBL] [Abstract][Full Text] [Related]
4. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.
Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M
Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564
[TBL] [Abstract][Full Text] [Related]
5. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
[TBL] [Abstract][Full Text] [Related]
6. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
Souza RF; Krishnan K; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
[TBL] [Abstract][Full Text] [Related]
7. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.
Kazumori H; Ishihara S; Rumi MA; Kadowaki Y; Kinoshita Y
Gut; 2006 Jan; 55(1):16-25. PubMed ID: 16118348
[TBL] [Abstract][Full Text] [Related]
8. CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.
Johnson DR; Abdelbaqui M; Tahmasbi M; Mayer Z; Lee HW; Malafa MP; Coppola D
World J Gastroenterol; 2015 Mar; 21(9):2770-6. PubMed ID: 25759548
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
10. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
11. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
12. P63 Deficiency and CDX2 Overexpression Lead to Barrett's-Like Metaplasia in Mouse Esophageal Epithelium.
Fang Y; Li W; Chen X
Dig Dis Sci; 2021 Dec; 66(12):4263-4273. PubMed ID: 33469811
[TBL] [Abstract][Full Text] [Related]
13. The role of Cdx2 in Barrett's metaplasia.
Colleypriest BJ; Farrant JM; Slack JM; Tosh D
Biochem Soc Trans; 2010 Apr; 38(2):364-9. PubMed ID: 20298184
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
Vega ME; Giroux V; Natsuizaka M; Liu M; Klein-Szanto AJ; Stairs DB; Nakagawa H; Wang KK; Wang TC; Lynch JP; Rustgi AK
Cell Cycle; 2014; 13(24):3857-66. PubMed ID: 25558829
[TBL] [Abstract][Full Text] [Related]
15. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.
Moons LM; Bax DA; Kuipers EJ; Van Dekken H; Haringsma J; Van Vliet AH; Siersema PD; Kusters JG
J Clin Pathol; 2004 Oct; 57(10):1063-8. PubMed ID: 15452161
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
[TBL] [Abstract][Full Text] [Related]
17. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
Mohammed IA; Streutker CJ; Riddell RH
Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
[TBL] [Abstract][Full Text] [Related]
18. Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett's esophagus.
Kong J; Crissey MA; Funakoshi S; Kreindler JL; Lynch JP
PLoS One; 2011 Apr; 6(4):e18280. PubMed ID: 21494671
[TBL] [Abstract][Full Text] [Related]
19. The role of nitric oxide in the induction of caudal-type homeobox 2 through epidermal growth factor receptor in the development of Barrett's esophagus.
Kusaka G; Uno K; Iijima K; Endo H; Asano N; Koike T; Imatani A; Shimosegawa T
Scand J Gastroenterol; 2012 Oct; 47(10):1148-58. PubMed ID: 22834965
[TBL] [Abstract][Full Text] [Related]
20. IL-4 induces columnar-like differentiation of esophageal squamous epithelium through JAK/PI3K pathway: possible role in pathogenesis of Barrett's esophagus.
Shan J; Oshima T; Farre R; Fukui H; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G641-9. PubMed ID: 24578343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
